That may sound strange, but swallowing tablets containing a gel mixture can help you lose weight.
“New Generation” treatments can help patients lose up to 10% of their weight in just three months. This is faster than a big hit jab like Ozempic.
Diet pills have a checkered history, and Xenical is approved for use in the UK for NHS. This is not very popular due to its operating mode.
The drug stops fat from being absorbed, allowing it to pass straight through the body.
However, this process can cause unpleasant stomach and intestinal problems, such as diarrhea. This suggests that people have stopped stopping it.
However, thousands of Slimers who are trying new weight loss drugs called Sirona have so far only been available as NHS trials, but have yet to report adverse effects.
Capsules that are consumed in a full water in the morning absorb liquids and expand in the stomach within just 30 minutes.
The mass of this gel takes up space in the stomach, enriches the patient physically, and theoretically leads to eating less and losing weight.
Thousands of Slimers who have tried a new pill called Sirona have so far only been available as a test in the NHS – has yet to report adverse side effects
The capsule is photographed in a full water in the morning, absorbing the water and expanding in the stomach within just 30 minutes. It is designed to enrich the patient, so in theory they eat less
The body mass index (BMI) of one trial participant reportedly fell to 31.2 in just 12 weeks after a solid increase in the obesity category of risk for diabetes, heart disease and other health conditions.
Once Gel does work, it won’t be absorbed by the body.
Instead, after staying in the stomach for several days, the material contracts and passes through the small intestine, entering the colon where it is broken.
After that, which material remains will come off the feces body.
“Sirona represents a new generation of weight loss treatments, particularly targeting obese patients and the resulting comorbidities,” said Dr. Asif Humayun, a Milton Keynes-based NHS endocrinologist who was involved in the NHS trial.
Dr Kamilaiaster, CEO of Oxford Medical Products, which manufactures capsules, added:
“As a highly differentiated weight loss injection supplement technique, Sirona addresses two important gaps: support overweight individuals and prevent weight recovery after injection treatment.”
The three-month clinical trial included 9,500 obese patients at three NHS hospitals in the southeastern and west of England.
Photographs, Oxford Medical Products, CEO, Dr. Kamilai-Ster (left), Chief Medical Officer, Professor Hutan Ashrafian (center), Chief Strategy Officer, Dr. Xue Min (right)
Participants were found to lose an average of 7.9 pounds (3.6 kg). This amounts to about 10% of your body weight in just under three months.
In comparison, those without structured diet or lifestyle interventions in the placebo group lost only 4.6% of their body weight on average.
Silona participants were found to consume an average of 400 calories less per day, and reported no serious adverse events.
One major TRIA (active ingredient in Ozempic) from 2022L semaglutide has shown that it helps users to drain around 3.6% of their body weight over three months.
Same study Tilzepatide, the ingredient behind Mounjaro, can help you lose about 5.9% of your body weight in 12 weeks.
Oxford Medical Products plans to conduct further research on Sirona in large-scale trials with more patients in both the US and the UK later this year.
They aim to use tablets primarily as a wide range of weight loss aids for use in connection with diet and exercise.
But they also hope that Sirona will be available to people who are overweight and not obese, and will fill the market gap.
This distinguishes it from weight loss jabs, medically known as glucagon-like peptide-1 receptor agonists.
And they hope that Oxford’s medical products can be used to help patients taking medications such as semaglutide to keep their weight down in the long term, rather than competing with injections.
There is evidence that people who have stopped taking GLP-1 medications can recover a significant amount of weight.
At least half a million NHS patients and around 15 million patients in the US are believed to be using weight loss injections.
But like other medications, the side effects are widespread and include issues like nausea, abdominal pain, severe digestive problems, and even bone pain.
Doctors also warn that they are treating increasingly slim women after becoming seriously ill after taking a jab that they mistakenly secured as obese to hand online chemists a eligibility check for injections.
